A research report reveals the "game" of BIOTEST BIOTECH's brain-computer interface同壁财经·Jun 3 at 06:35 PM688767+6.68%
AI TRENDS | Brain-Computer Interface Technology Set for Commercial Expansion by 2026CoinLive·Apr 5 at 07:34 PM688626+5.52%159998+5.89%
Brain-computer interfaces are becoming a reality, with over 100 institutions researching 5 concept stocks this year36Kr·Mar 23 at 06:57 PM300753+2.96%301330+4.71%
The A-share brain-computer interface concept is actively defying the trend, with BIOTEST BIOTECH rising over 10%, and Meihao Medical, Sanbo, APON, and Xiangyu Medical following suitWallstreetcn·Feb 13 at 12:14 AM688767+6.68%300753+2.96%
The three major A-share indices collectively closed higher, with the Shanghai Composite Index returning to 4,000 points36Kr·Jan 5 at 01:07 AM603598+9.99%688767+6.68%
Multiple A-share companies reveal progress and product updates in brain-computer interface technologyZhitong·Sep 11, 2025 at 05:23 PM688273+4.05%688767+6.68%
BIOTEST BIOTECH released its semi-annual performance, with a net profit attributable to the parent company of 12.4 million yuan, a year-on-year decrease of 82.82%Zhitong·Aug 28, 2025 at 03:40 AM688767+6.68%
BIOTEST BIOTECH: Xu Ping plans to reduce her holdings by 3% starting in SeptemberZhitong·Aug 20, 2025 at 06:11 AM688767+6.68%
Gao Hongmei, a director of BIOTEST BIOTECH, completed a reduction in holdings, with a total reduction of 560,000 sharesZhitong·May 27, 2025 at 03:39 AM688767+6.68%
BIOTEST BIOTECH: Wholly-owned subsidiary Botai Zhito strategically invests in Zhejiang University Brain-Machine Interface Achievement Transformation ProjectZhitong·May 21, 2025 at 08:24 PM688767+6.68%
BIOTEST BIOTECH: Net profit in 2024 increased by 59.01% year-on-yearZhitong·Apr 25, 2025 at 06:58 AM688767+6.68%
BIOTEST BIOTECH: Net profit in the first quarter of 2025 was 8.7324 million yuan, a year-on-year decrease of 77.97%Zhitong·Apr 25, 2025 at 06:58 AM688767+6.68%
BIOTEST BIOTECH: The net profit for the year 2024 is 177 million yuan, a year-on-year increase of 65.74%Zhitong·Feb 26, 2025 at 02:24 AM688767+6.68%
BIOTEST BIOTECH director Gao Hongmei plans to reduce holdings of no more than 560,000 sharesZhitong·Feb 6, 2025 at 05:27 AM688767+6.68%
